Move to the main navigation Open the search Move to the main content Move to the end of the page

"For me, bioeconomy means not only but also the application of biotechnical processes for the sustainable production of food, medicines and (raw) materials ."

Dr. Viola Bronsema

CEO and Secretary General of the German Biotech Association BIO Deutschland, Member of the Council on Technological Sovereignty of Federal Ministry of Research

The most important stages of the career

since 2006
Managing Director of the Biotechnology Industry Organisation Germany e.V.

Head of Communications of Roche Diagnostics GmbH and Roche Diagnostics Europe Middle East Africa (EMEA), Mannheim

Spokesperson Press and Public Relations of Lilly Pharma Holding GmbH

Press spokesperson and editor in the press and public relations department of the German Cancer Research Centre (DKFZ), Heidelberg

Public relations consultant at CGC Cramer-Gesundheits-Consulting, Frankfurt

Doctorate Centre for Molecular Biology in Heidelberg based on work on the dissertation at the Centre for Molecular Biology, Heidelberg, supervised by Prof. Dr. H. Schaller; topic jaundice/hepatitis B: "Representation and functional investigation of the P gene product of the hepadnaviruses

Activities and Memberships

since 2021
Member of the Contribution Council for Technological Sovereignty of the BMBF

since 2020
Member of the Supervisory Board of Curevac AG and Curevac N.V.

since 2017
Member of the Advisory Board WPCD Wirtschaftspolitischer Club Deutschland e.V.

since 2012
Member of the Advisory Board VBIO Verband Biologie, Biowissenschaften und Biomedizin in Deutschland e. V.


Viola Bronsema is an experienced member of the biotechnology ecosystem. She has been Managing Director of the Biotechnology Industry Organization Germany (BIO Deutschland) in Berlin since October 2006. Prior to that, she was head of communications at Roche Diagnostics GmbH and Roche Diagnostics Europe, Middle East, Africa, among others. Viola Bronsema studied biology at the Universities of Mainz and Heidelberg and completed her doctoral thesis at the Center for Molecular Biology in Heidelberg. She then worked in press and public relations at the German Cancer Research Center (DKFZ) in Heidelberg, among other positions. She has been a member of the Supervisory Board of CureVac N. V. since August 2020.


  • (Technical) innovations
  • Transformation of the industry
  • Contribution of the Bioeconomy

Future Challenges

  • Food and health
  • Fixation and use of CO2 
  • Reduction of land use pressure
Follow us on